77166 Federal Register / Vol. 89, No. 183 / Friday, September 20, 2024 / Notices 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Dental and Craniofacial Research Special 

Emphasis Panel; Review of Mentoring 

Network (UE5), DSR Member-Conflict (K), 

and Conference (R13) Grant Applications. 

Date: October 29, 2024. 

Time: 1:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Dental & 

Craniofacial Research 31 Center Drive 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Jingshan Chen, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, Division of Extramural Activities, 

National Institute of Dental & Craniofacial 

Research, 31 Center Drive, Bethesda, MD 

20892 (301) 451–2405 email: jingshan.chen@

nih.gov. 

Name of Committee: National Institute of 

Dental and Craniofacial Research Special 

Emphasis Panel; Review of Clinical Study 

Applications. 

Date: October 30, 2024. 

Time: 12:00 p.m. to 6:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Dental & 

Craniofacial Research 31 Center Drive 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Yun Mei, MD Scientific 

Review Officer Scientific Review Branch 

National Institute of Dental & Craniofacial 

Research National Institutes of Health 31 

Center Drive Bethesda, MD 20892 (301) 827– 

4639 email: yun.mei@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program No. 93.121, Oral Diseases and 

Disorders Research, National Institutes of 

Health, HHS) 

Dated: September 17, 2024. 

Bruce A. George, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–21589 Filed 9–19–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center For Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Bioengineering 

Sciences & Technologies Integrated Review 

Group; Biodata Management and Analysis 

Study Section. 

Date: October 17–18, 2024. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: E. Bryan Crenshaw, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, (301) 480–7129, bryan.crenshaw@

nih.gov. 

Name of Committee: Population Sciences 

and Epidemiology Integrated Review Group; 

Lifestyle and Health Behaviors Study 

Section. 

Date: October 17–18, 2024. 

Time: 9:30 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: AC Hotel, 4646 Montgomery Ave., 

Bethesda, MD 20814. 

Contact Person: Jewel L Wright, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, (301) 827–9038, jewel.wright@nih.gov. 

Name of Committee: Oncology 1—Basic 

Translational Integrated Review Group; 

Tumor Host Interactions Study Section. 

Date: October 17–18, 2024. 

Time: 9:30 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Angela Y Ng, Ph.D., MBA, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 710–C, 

MSC 7806, Bethesda, MD 20892, (301) 435– 

1715, nga@csr.nih.gov. 

Name of Committee: Emerging 

Technologies and Training Neurosciences 

Integrated Review Group; Imaging 

Technology for Neuroscience Study Section. 

Date: October 21–22, 2024. 

Time: 7:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Ritz-Carlton Hotel, 1700 Tysons 

Boulevard, McLean, VA 22102. 

Contact Person: Rachel A Kane, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Dr., Bethesda, MD 

20892, (301) 496–0221, kanera@csr.nih.gov. 

Name of Committee: Oncology 2— 

Translational Clinical Integrated Review 

Group; Clinical Oncology Study Section. 

Date: October 21–22, 2024 

Time: 8:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Watergate, 2650 Virginia 

Avenue NW, Washington, DC 20037. 

Contact Person: Laura Asnaghi, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institute of 

Health, 6701 Rockville Drive, Room 6200, 

MSC 7804 Bethesda, MD 20892, (301) 443– 

1196, laura.asnaghi@nih.gov. 

Name of Committee: Applied Immunology 

and Disease Control Integrated Review 

Group; Interspecies Microbial Interactions 

and Infectious Study Section. 

Date: October 21, 2024. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites Alexandria Old 

Town, 1900 Diagonal Road, Alexandria, VA 

22314. 

Contact Person: Subhamoy Pal, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, (301) 594–0926, subhamoy.pal@

nih.gov. 

Name of Committee: Genes, Genomes, and 

Genetics Integrated Review Group; Genetics 

of Health and Disease Study Section. 

Date: October 21–22, 2024. 

Time: 9:00 a.m. to 9:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Christopher Payne, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Rm. 2208, 

Bethesda, MD 20892, 301–402–3702 

christopher.payne@nih.gov. 

Name of Committee: Integrative, 

Functional and Cognitive Neuroscience 

Integrated Review Group; Neurotoxicology 

and Alcohol Study Section. 

Date: October 21–22, 2024. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Eileen Marie Moore, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, (301) 594–8928, eileen.moore@

nih.gov. 

Name of Committee: Risk, Prevention and 

Health Behavior Integrated Review Group; 

Clinical Management in General Care 

Settings Study Section. 

Date: October 21–22, 2024. 


ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 89, No. 183 / Friday, September 20, 2024 / Notices 77167 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Canopy by Hilton, 940 Rose Avenue, 

North Bethesda, MD 20852. 

Contact Person: Jessica Campbell 

Chambers, Ph.D., Scientific Review Officer, 

Center for Scientific Review, National 

Institutes of Health, 6701 Rockledge Drive, 

Bethesda, MD 20892, (301) 496–5693, 

jessica.chambers@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: September 16, 2024. 

Lauren A. Fleck, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–21501 Filed 9–19–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

Coast Guard 

[Docket No. USCG–2024–0781] 

National Chemical Transportation 

Safety Advisory Committee; October 

2024 Meeting 

AGENCY: Coast Guard, Department of 

Homeland Security. 

ACTION: Notice of open Federal advisory 

committee meetings. 

SUMMARY: The National Chemical 

Transportation Safety Advisory 

Committee (Committee) and its three 

subcommittees will meet in public in 

Washington, DC to discuss matters 

relating to the safe and secure marine 

transportation of hazardous materials. 

The Committee will be held in person 

only. The three subcommittee meetings 

will be virtual. For more detailed 

information regarding the subcommittee 

meetings, see Agenda Day 1 and Day 2 

below. 

DATES: 

Four Open Meetings: (1) The Support 

Reductions to Emissions and 

Environmental Impacts Associated with 

Marine Transport of Chemicals, 

Liquefied Gases and Liquefied Natural 

Gas (LNG); Including the Working 

Group on the update to 46 CFR 150 

concerning Cargo Compatibility Testing 

subcommittee will meet virtually on 

Tuesday, October 8, 2024, from 2 p.m. 

to 5 p.m. Eastern Daylight Time (EDT). 

If the subcommittee has completed its 

business the meeting may end early. (2) 

The Industry Best Practices and 

Regulatory Updates Related to the 

Maritime Transportation of Lithium 

Batteries subcommittee will meet 

virtually on Wednesday, October 9, 

2024, from 9 a.m. to noon EDT. If the 

subcommittee has completed its 

business the meeting may end early. (3) 

The Updates to CG–ENG Policy Letter 

02–15: Design Standards For U.S. Barges 

Intending to Carry Liquefied Natural 

Gas in Bulk subcommittee will meet 

virtually on Wednesday, October 9, 

2024, from 1:30 p.m. to 5 p.m. EDT. If 

the subcommittee has completed its 

business the meeting may end early. (4) 

The National Chemical Transportation 

Safety Advisory Committee will meet 

in-person on Thursday, October 10, 

2024, from 9 a.m. to 2 p.m. EDT. If the 

Committee has completed its business 

the meeting may end early. 

The subcommittee taskings and other 

subcommittee information can be found 

using the following address: https://

homeport.uscg.mil/missions/federaladvisory-committees/national-chemicaltransportation-safety-advisorycommittee-(nctsac)/task-statements. 

Comments and supporting 

documents: To ensure your comments 

are received by Committee and 

subcommittee members before the 

meetings, submit your written 

comments no later than September 24, 

2024. Please specify to whom your 

comments are directed: the Committee 

or the subcommittees. 

ADDRESSES: The National Chemical 

Transportation Safety Advisory 

Committee meeting will be held at the 

American Bureau of Shipping Group, 80 

M Street Southeast, Suite 480, 

Washington, DC 20003. 

Pre-registration Information: Preregistration is required for in-person 

access to the full Committee meeting or 

to attend the subcommittee meetings via 

videoconference. Public attendees will 

be required to pre-register no later than 

noon EDT on September 24, 2024, to be 

admitted to the meetings. In-person 

attendance may be capped due to 

limited space in the meeting venue, and 

registration will be on a first-come-firstserved basis. To pre-register, contact 

Lieutenant Joseph Kolb at 

Joseph.B.Kolb2@uscg.mil. You will be 

asked to provide your name, telephone 

number, email, company or group with 

which you are affiliated, and whether 

you wish to attend virtually for 

subcommittee meetings or in person for 

full Committee meeting. If you wish to 

attend virtually, please also provide the 

subcommittee meeting(s) you wish to 

attend. 

The National Chemical 

Transportation Safety Advisory 

Committee is committed to ensuring all 

participants have equal access 

regardless of disability status. If you 

require reasonable accommodation due 

to a disability to fully participate, please 

email Lieutenant Joseph Kolb at 

Joseph.B.Kolb2@uscg.mil or call at 206– 

815–1623 as soon as possible. 

Instructions: You are free to submit 

comments at any time, including orally 

at the meetings as time permits, but if 

you want Committee or subcommittee 

members to review your comment 

before the meetings, please submit your 

comments no later than September 24, 

2024. We are particularly interested in 

comments on the topics in the 

‘‘Agenda’’ section below. We encourage 

you to submit comments through the 

Federal Decision Making Portal at 

https://www.regulations.gov. To do so, 

go to https://www.regulations.gov, type 

USCG–2024–0781 in the search box, 

and click ‘‘Search’’. Next, look for this 

document in the Search Results column 

and click on it. Then click on the 

Comment option. If your material 

cannot be submitted using https://

www.regulations.gov, contact the 

individual in the FOR FURTHER

INFORMATION CONTACT section of this 

document for alternate instructions. You 

must include the docket number 

[USCG–2024–0781]. Comments received 

will be posted without alteration at 

https://www.regulations.gov, including 

any personal information provided. You 

may wish to review the Privacy and 

Security Notice found via a link on the 

homepage of https://

www.regulations.gov, and the 

Department of Homeland Security’s 

eRulemaking System of Records notice 

(85 FR 14226, March 11, 2020). If you 

encounter technical difficulties with 

comment submission, contact the 

individual listed in the FOR FURTHER

INFORMATION CONTACT section of this 

notice. 

Docket Search: Documents mentioned 

in this notice as being available in the 

docket, and all public comments, will 

be in the online docket at https://

www.regulations.gov and can be viewed 

by following that website’s instructions. 

Additionally, if you go to the online 

docket and sign-up for email alerts, you 

will be notified when comments are 

posted. 

FOR FURTHER INFORMATION CONTACT: 

Lieutenant Joseph Kolb, Alternate 

Designated Federal Officer of the 

National Chemical Transportation 

Safety Advisory Committee, telephone 

206–815–1623, or email 

Joseph.B.Kolb2@uscg.mil. 

SUPPLEMENTARY INFORMATION: Notice of 

these meetings is in compliance with 

the Federal Advisory Committee Act, 


ddrumheller on DSK120RN23PROD with NOTICES1